Original Source(s)
Related Content
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min
Pregnancy Risks With First Trimester GLP-1 Continuation
Claims-based target trial emulation found no clear association between continued GLP-1 receptor agonist use in early pregnancy and nonlive birth, fetal growth abnormalities, or major congenital malformations.
June 17, 2026
-
3 min
Top 10 States Offering Large Physician Loan Repayment Programs
These states offer physician loan repayment and student loan forgiveness programs through state-supported workforce initiatives.
June 22, 2026
-
3 min